Residual Risk for Clinically Significant Copy Number Variants in Low-Risk Pregnancies, Following Exclusion of Noninvasive Prenatal Screening–Detectable Findings. Issue 10 (October 2022)

• Record Type: Journal Article
• Authors: Maya, Idit; Sheelo, Liat Salzer; Brabbing-Goldstein, Dana; Matar, Reut; Kahana, Sarit; Agmon-Fishman, Ifaat; Klein, Cochava; Gurevitch, Merav; Basel-Salmon, Lina; Sagi-Dain, Lena
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 10(2022)
• Page Start: 574
• Page End: 576
• Publication Date: 2022-10
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000892136.51069.d6
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Am J Obstet Gynecol 2022;226:562.e1–562.e8) Recent developments in available techniques for prenatal genetic analysis have significantly changed genetic screening and diagnosis; these include chromosomal microarray analysis (CMA) and cell-free DNA (cfDNA) screening. However, both tests have benefits and drawbacks.